Characterize the Links Between Sleep, Emotional Dysregulation and Learning in Neurodevelopmental Disorders.

NCT ID: NCT06479668

Last Updated: 2024-08-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-01

Study Completion Date

2027-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this protocol is to disentangle the links between symptoms of emotion dysregulation, sleep disorders and cognitive deficits by measuring the effects of an emotional induction task on childrens' sleep with autism spectrum disorders (ASD) and attention deficit hyperactivity disorder (ADHD).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Attention Deficit Disorder With or Without Hyperactivity (ADHD) Autism Spectrum Disorder (ASD)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Autism Spectrum Disorder

Group Type EXPERIMENTAL

Trier Social Stress Task

Intervention Type BEHAVIORAL

Specify details not covered in associated Arm Description.

Attention Deficit Disorder with or without Hyperactivity

Group Type EXPERIMENTAL

Trier Social Stress Task

Intervention Type BEHAVIORAL

Specify details not covered in associated Arm Description.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Trier Social Stress Task

Specify details not covered in associated Arm Description.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects aged 7 to 12
* Able to receive clear, age-appropriate information and to participate fully in the study
* Whose legal representative(s) are able to understand the objectives and risks of the research and to give their dated and signed informed consent.
* Subjects benefiting from a social health insurance plan (beneficiary of the legal representative(s))
* With a diagnosis made prior to inclusion of Autism Spectrum Disorder (ASD) or Attention Deficit Disorder with or without Hyperactivity (ADHD) as defined by Diagnostic and Statistical Manual 5 (DSM-5).
* With abbreviated intelligence quotient \> 80 measured by Wechsler Intelligence Scale for Children version IV (WISC-IV )no more than 6 months prior to research inclusion
* No diagnosis of: fragile X syndrome, Rett syndrome, trisomy 21, tuberous sclerosis of Bourneville, von Recklinghausen disease, Cytomegalovirus encephalitis (CMV encephalitis), congenital rubella, phenylketonuria
* No clinically significant abnormality which, in the investigator's opinion, could interfere with the implementation of the study.

Exclusion Criteria

\- Current or past neurological problem(s) (e.g. stroke, epilepsy, meningitis, head trauma with loss of consciousness of more than 15 min, concussion, brain tumor, ...).

tumor, ...)

* Transmeridian travel (\> 2 time zones) in the month prior to study inclusion
* Presence of a mood disorder (bipolar disorder or depression) according to DSM-5 criteria
* Social jet-lag \> 2 hours (mid-point of sleep differential during weekends vs. weekdays)
* Modification of psychotropic medication in the 2 months prior to inclusion
* Use of melatonin-based dietary supplement(s)/medication(s) in the 24 hours prior to study inclusion
* Use of psychostimulant(s) within 48 hours of study entry
* Extreme chronotype (Morningness/Eveningness questionnaire score \< 10 or \> 42)
* Cognitive-behavioral therapies (CBT) targeting sleep disorders
* Participation in research involving an experimental drug which may interfere with the protocol\*.
* Minor under guardianship
* Subject in a period of exclusion (determined by a previous or current study)
* Subject in emergency situation
Minimum Eligible Age

7 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Strasbourg, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Carmen Schroder, MD

Role: CONTACT

0033388116218

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

9094

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Melatonin and Sleep Spindles in Autism
NCT05716906 ACTIVE_NOT_RECRUITING NA